Nuwellis Competitors

NUWE Stock  USD 2.47  0.55  18.21%   
Nuwellis competes with PetVivo Holdings, SAB Biotherapeutics, INVO Fertility, and Aclarion; as well as few others. The company conducts business under Health Care Equipment & Supplies sector and is part of Health Care industry. Analyzing Nuwellis competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Nuwellis to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Nuwellis Correlation with its peers.
For information on how to trade Nuwellis Stock refer to our How to Trade Nuwellis Stock guide.

Nuwellis vs Aclarion Correlation

Good diversification

The correlation between Nuwellis and ACON is -0.2 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Nuwellis and ACON in the same portfolio, assuming nothing else is changed.

Moving against Nuwellis Stock

  0.49HAE HaemoneticsPairCorr
  0.31XTNT Xtant Medical HoldingsPairCorr
As of February 7, 2026, Return On Tangible Assets is expected to decline to -1.37. In addition to that, Return On Capital Employed is expected to decline to -1.82. At present, Nuwellis' Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 309.9 K, whereas Non Currrent Assets Other are forecasted to decline to about 18 K.
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nuwellis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.122.3515.17
Details
Intrinsic
Valuation
LowRealHigh
0.234.5517.37
Details
Naive
Forecast
LowNextHigh
0.052.4715.30
Details
1 Analysts
Consensus
LowTargetHigh
10.0111.0012.21
Details

Nuwellis Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Nuwellis and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Nuwellis and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Nuwellis does not affect the price movement of the other competitor.

High positive correlations

ACONPETV
ACONBCTXW
BCTXWPETV
IVFVINC
IVFPETV
ACONIVF
  

High negative correlations

SABSPETV
ACONSABS
BCTXWSABS
IVFSABS
VINCSABS
IVFBACK

Risk-Adjusted Indicators

There is a big difference between Nuwellis Stock performing well and Nuwellis Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Nuwellis' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
PETV  3.71 (0.45) 0.00  19.64  0.00 
 7.55 
 32.58 
OCEA  55.12  22.49  0.57 (2.94) 28.38 
 166.67 
 473.33 
SABS  2.90  0.47  0.10 (1.52) 3.31 
 6.13 
 22.52 
BACK  16.38  3.55  0.18 (1.31) 13.79 
 37.80 
 271.43 
BCTXW  8.88 (2.08) 0.00 (6.19) 0.00 
 14.21 
 61.85 
VINC  5.48  0.62  0.03  0.37  13.09 
 10.00 
 127.90 
PKBO  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
IVF  10.60  0.40  0.00  0.03  0.00 
 12.22 
 218.36 
NUVO  33.64  11.96  0.17 (2.53) 21.20 
 66.67 
 544.44 
ACON  5.45 (1.26) 0.00 (0.72) 0.00 
 10.31 
 83.58 

Cross Equities Net Income Analysis

Compare Nuwellis and related stocks such as PetVivo Holdings, Ocean Biomedical, and SAB Biotherapeutics Net Income Over Time
Select Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Shareholders Equity Per ShareDebt To Equity
Capex Per ShareGraham Net Net
Average ReceivablesRevenue Per Share
Interest Debt Per ShareDebt To Assets
Enterprise Value Over E B I T D AShort Term Coverage Ratios
Price Earnings RatioOperating Cycle
Price Book Value RatioPrice Earnings To Growth Ratio
Days Of Payables OutstandingDividend Payout Ratio
Price To Operating Cash Flows RatioPrice To Free Cash Flows Ratio
Pretax Profit MarginEbt Per Ebit
Operating Profit MarginEffective Tax Rate
Company Equity MultiplierLong Term Debt To Capitalization
Total Debt To CapitalizationReturn On Capital Employed
Debt Equity RatioEbit Per Revenue
Quick RatioDividend Paid And Capex Coverage Ratio
Net Income Per E B TCash Ratio
Cash Conversion CycleOperating Cash Flow Sales Ratio
Days Of Inventory OutstandingDays Of Sales Outstanding
Free Cash Flow Operating Cash Flow RatioCash Flow Coverage Ratios
Price To Book RatioFixed Asset Turnover
Capital Expenditure Coverage RatioPrice Cash Flow Ratio
Enterprise Value MultipleDebt Ratio
Cash Flow To Debt RatioPrice Sales Ratio
Return On AssetsAsset Turnover
Net Profit MarginGross Profit Margin
Price Fair ValueReturn On Equity
20102011201220132014201520162017201820192020202120222023202420252026
SABS(9 M)(9 M)(9 M)(9 M)(9 M)(9 M)(9 M)(9 M)(9 M)(9 M)20.1 M(17.1 M)(18.7 M)(42.2 M)(34.1 M)(30.7 M)(29.2 M)
BCTXW(8.6 K)(995.7 K)(368.7 K)(8.9 M)(2.7 M)(1.7 M)(2.6 M)(5.4 K)(6.2 K)1.4 M(2.9 M)(11.6 M)(20.3 M)(6.6 K)(36.5 M)(32.8 M)(31.2 M)
VINC(54 K)(54 K)(54 K)(54 K)(54 K)(54 K)(54 K)(54 K)(54 K)(54 K)(10.7 M)(39.3 M)(65.4 M)(40.2 M)(30.1 M)(27.1 M)(28.4 M)
IVF(7.4 K)(797.5 K)(666.5 K)(760.7 K)(1.7 M)(5 M)(2.1 M)(702.2 K)(3.1 M)(2.2 M)(8.3 M)(6.7 M)(10.9 M)(8 M)(9.1 M)(8.2 M)(7.8 M)
ACON(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4 M)(4.6 M)(5 M)(7.1 M)(4.9 M)(7 M)(6.3 M)(6.6 M)

Nuwellis and related stocks such as PetVivo Holdings, Ocean Biomedical, and SAB Biotherapeutics Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Nuwellis financial statement analysis. It represents the amount of money remaining after all of Nuwellis operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.

Nuwellis Competitive Analysis

The better you understand Nuwellis competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Nuwellis' competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Nuwellis' competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
NUWE PETV OCEA SABS BACK BCTXW VINC IVF NUVO ACON
 18.21 
 2.47 
Nuwellis
 1.18 
 0.86 
PetVivo
 21.43 
 0 
Ocean
 4.77 
 4.17 
SAB
 0.12 
 0.08 
IMAC
 9.18 
 0.01 
BriaCell
 1.57 
 0.01 
Vincerx
 4.76 
 1.10 
INVO
 0.00 
 0.0001 
Holdco
 16.53 
 2.75 
Aclarion
Market Volatility
(90 Days Market Risk)
Market Performance
(90 Days Performance)
Odds of Financial Distress
(Probability Of Bankruptcy)
Current Valuation
(Equity Enterprise Value)
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Current Ratio
Net Asset
Profit Margin
EBITDA
Operating Margin
Current Valuation
Price To Book
Retained Earnings
Current Asset
Beta
Number Of Employees
Shares Outstanding
Cash Flow From Operations
Total Debt
Return On Equity
Z Score
Return On Asset
Number Of Shares Shorted
Book Value Per Share
Current Liabilities
Total Asset
Debt To Equity
Short Ratio
Target Price
Shares Owned By Institutions
Market Capitalization
Price To Earning
Price To Sales
Net Income
Earnings Per Share
Shares Owned By Insiders
Revenue
Working Capital
Cash And Equivalents
Cash Per Share
Gross Profit
Day Typical Price
Accumulation Distribution
Market Facilitation Index
Daily Balance Of Power
Period Momentum Indicator
Rate Of Daily Change
Day Median Price
Price Action Indicator
Coefficient Of Variation
Mean Deviation
Jensen Alpha
Total Risk Alpha
Sortino Ratio
Downside Variance
Standard Deviation
Kurtosis
Potential Upside
Treynor Ratio
Maximum Drawdown
Variance
Market Risk Adjusted Performance
Risk Adjusted Performance
Skewness
Semi Deviation
Information Ratio
Value At Risk
Expected Short fall
Downside Deviation
Semi Variance

Nuwellis Competition Performance Charts

Five steps to successful analysis of Nuwellis Competition

Nuwellis' competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Nuwellis in relation to its competition. Nuwellis' competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Nuwellis in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Nuwellis' competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Nuwellis, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Nuwellis position

In addition to having Nuwellis in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Real Estate Thematic Idea Now

Real Estate
Real Estate Theme
Publicly traded companies that are involved in real estate development, property maintenance and management of real estate investment trusts (REIT) funds. The Real Estate theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Real Estate Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Nuwellis is a strong investment it is important to analyze Nuwellis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Nuwellis' future performance. For an informed investment choice regarding Nuwellis Stock, refer to the following important reports:
Check out Nuwellis Correlation with its peers.
For information on how to trade Nuwellis Stock refer to our How to Trade Nuwellis Stock guide.
You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Will Health Care Equipment & Supplies sector continue expanding? Could Nuwellis diversify its offerings? Factors like these will boost the valuation of Nuwellis. Anticipated expansion of Nuwellis directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Nuwellis data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
(0.99)
Earnings Share
(250.62)
Revenue Per Share
27.778
Quarterly Revenue Growth
(0.06)
Return On Assets
(0.93)
Investors evaluate Nuwellis using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Nuwellis' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Nuwellis' market price to deviate significantly from intrinsic value.
It's important to distinguish between Nuwellis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nuwellis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nuwellis' market price signifies the transaction level at which participants voluntarily complete trades.